Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) EPS (Weighted Average and Diluted) (2018 - 2025)

Viemed Healthcare's EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at $0.14 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 27.27% year-over-year to $0.14; the TTM value through Dec 2025 reached $0.37, up 27.59%, while the annual FY2025 figure was $0.37, 32.14% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.14 in Q4 2025 per VMD's latest filing, up from $0.09 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.14 in Q4 2025 to a low of $0.02 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.06, with a median of $0.06 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 91.67% in 2021, then soared 200.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.1 in 2021, then decreased by 30.0% to $0.07 in 2022, then increased by 14.29% to $0.08 in 2023, then soared by 37.5% to $0.11 in 2024, then increased by 27.27% to $0.14 in 2025.
  • Per Business Quant, the three most recent readings for VMD's EPS (Weighted Average and Diluted) are $0.14 (Q4 2025), $0.09 (Q3 2025), and $0.08 (Q2 2025).